51
|
Jerônimo AFDA, Freitas ÂGQ, Weller M. Risk factors of breast cancer and knowledge about the disease: an integrative revision of Latin American studies. CIENCIA & SAUDE COLETIVA 2018; 22:135-149. [PMID: 28076537 DOI: 10.1590/1413-81232017221.09272015] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2015] [Accepted: 10/24/2015] [Indexed: 11/22/2022] Open
Abstract
The aim of this integrative review was to compare Latin American literature about risk and knowledge on breast cancer. Of 47 studies selected, 20 were about knowledge or awareness and 27 about risk of breast cancer. English was the dominant language in studies about risk, whereas studies about knowledge were mainly written in Spanish or Portuguese. Studies about knowledge were all cross- sectional, whereas case- control studies dominated authors' interest about risk of breast cancer. Studies about knowledge were mainly focused on early detection of the disease and the most common study objective was breast self- examination (N = 14). In contrast, few studies about risk of breast cancer focused on early detection (N = 5). Obesity and overweight (N = 14), family history (N = 13), decreased parity (N = 12), and short breastfeeding duration (N = 10) were among the most frequent identified risk factors. Socio- economic factors such as income and educational level had variable effects on breast cancer risk and affected also knowledge of women about risk factors and early detection. Present results indicated that studies about risk of breast cancer were more often based on a better sound analytical background, compared to studies about knowledge, which were mostly descriptive.
Collapse
Affiliation(s)
- Aline Ferreira de Araújo Jerônimo
- Programa de Pós-Graduação em Saúde Pública, Universidade Estadual da Paraíba. R. Baraúnas 351, Universitário. 58429-500 Campina Grande PB Brasil.
| | - Ângela Gabrielly Quirino Freitas
- Programa de Pós-Graduação em Saúde Pública, Universidade Estadual da Paraíba. R. Baraúnas 351, Universitário. 58429-500 Campina Grande PB Brasil.
| | - Mathias Weller
- Programa de Pós-Graduação em Saúde Pública, Universidade Estadual da Paraíba. R. Baraúnas 351, Universitário. 58429-500 Campina Grande PB Brasil.
| |
Collapse
|
52
|
Costa RFA, Longatto-Filho A, de Lima Vazquez F, Pinheiro C, Zeferino LC, Fregnani JHTG. Trend analysis of the quality indicators for the Brazilian cervical cancer screening programme by region and state from 2006 to 2013. BMC Cancer 2018; 18:126. [PMID: 29394915 PMCID: PMC5797416 DOI: 10.1186/s12885-018-4047-9] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2017] [Accepted: 01/24/2018] [Indexed: 11/21/2022] Open
Abstract
Background Quality indicators for the Brazilian cervical cancer screening programme can provide a perspective on its effectiveness in Brazilian macro-regions and states. The aim of this study was to perform a trend analysis of the cervical cancer screening program’s quality indicators, according to Brazilian regions and states, from 2006 to 2013. Methods Using information from approximately 62,000,000 exams obtained from the Information System of Cervical Cancer Screening (SISCOLO), joinpoint analysis was used to calculate the Annual Percentage Change (APC). Results The estimated number of women in the target age group (25–64 years) who underwent Pap testing over a three-year interval was lower than that recommended by international guidelines in the North, Northeast and Midwest regions, and the trends for this indicator remained stationary over the years in all regions of Brazil. Overall, the index of positivity in Brazilian regions and states is below that preconized by the Brazilian National Cancer Institute (INCA). Additionally, the frequencies of unsatisfactory cases are in line with international guidelines but above those preconized by INCA guidelines. All positive cytological diagnoses were lower than those preconized by INCA. Conclusions The results show that the cervical cancer screening programme is still far from efficient because most of the quality indicators in Brazilian regions and states are outside of the parameters preconized by national and international organizations. Electronic supplementary material The online version of this article (10.1186/s12885-018-4047-9) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Ricardo Filipe Alves Costa
- Graduate Program on Oncology, Barretos Cancer Hospital, Barretos, São Paulo, 14784-400, Brazil. .,Barretos School of Health Sciences Dr. Paulo Prata - FACISB, Avenida Loja Maçonica Renovadora 68, N° 100, Bairro Aeroporto, Barretos, SP, 14785-002, Brazil.
| | - Adhemar Longatto-Filho
- Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, 14784-400, Brazil.,Laboratory of Medical Investigation (LIM 14), Faculty of Medicine São Paulo University, FMUSP, São Paulo, 01246-903, Brazil.,Life and Health Sciences Research Institute, ICVS, School of Health Sciences, Uminho University, 4710, Braga, Portugal.,ICVS/3B's - PT Government Associate Laboratory, 4710, Braga/Guimarães, Portugal
| | - Fabiana de Lima Vazquez
- Research and Teaching Institute, Barretos Cancer Hospital, Barretos, São Paulo, 14784-400, Brazil
| | - Céline Pinheiro
- Barretos School of Health Sciences Dr. Paulo Prata - FACISB, Avenida Loja Maçonica Renovadora 68, N° 100, Bairro Aeroporto, Barretos, SP, 14785-002, Brazil.,Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, 14784-400, Brazil
| | - Luiz Carlos Zeferino
- School of Medical Sciences, Women's Hospital CAISM, Unicamp, Campinas, São Paulo, 13081-940, Brazil
| | | |
Collapse
|
53
|
Couto MSDA, Guerra MR, Firme VDAC, Bustamante-Teixeira MT. [Breast cancer mortality in Brazilian municipalities and associated factorsMortalidad por cáncer de mama en municipios brasileños y factores asociados]. Rev Panam Salud Publica 2017; 41:e168. [PMID: 31391844 PMCID: PMC6660857 DOI: 10.26633/rpsp.2017.168] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2017] [Accepted: 08/09/2017] [Indexed: 12/28/2022] Open
Abstract
Objetivo. Analisar o comportamento da mortalidade por câncer de mama nos municípios brasileiros e avaliar a influência de fatores socioeconômicos e demográficos sobre as taxas e mortalidade. Métodos. Foram calculadas taxas de mortalidade, padronizadas por faixa etária e corrigidas por causas mal definidas, centradas em 1990, 2000 e 2010. Posteriormente, foram estimados modelos de regressão, com dados em painel, que permitiram verificar o grau de associação entre os fatores de interesse e a taxa de mortalidade pela doença. Resultados. Verificou-se uma tendência de crescimento da mortalidade no país. Contudo, os modelos indicaram que a mortalidade poderia ter diminuído (tendência negativa), principalmente no Sudeste e Sul, caso alguns fatores associados à doença (por exemplo, nível de renda, educação, longevidade, taxa de fecundidade, gastos em saúde, infraestrutura, entre outros) tivessem permanecido constantes durante o período considerado. Observou-se que a mortalidade por câncer de mama apresentou associação positiva/significativa com a longevidade e negativa/significativa com o nível de gastos públicos em saúde. A mortalidade foi maior nas regiões Sul e Sudeste, nos municípios com mais de 500 000 habitantes e naqueles onde a população é inferior a 5 000. Conclusões. O crescimento da renda per capita, a elevação da expectativa de vida e a diminuição da taxa de fecundidade podem estar associados a elevadas taxas de mortalidade por câncer de mama e a uma tendência de crescimento na mortalidade por esse câncer nos municípios brasileiros.
Collapse
Affiliation(s)
- Maria Silvia de Azevedo Couto
- Universidade Federal de Juiz de Fora (UFJF) Programa de Pós-Graduação em Saúde Coletiva Juiz de Fora (MG) Brasil Universidade Federal de Juiz de Fora (UFJF), Programa de Pós-Graduação em Saúde Coletiva, Juiz de Fora (MG), Brasil
| | - Maximiliano Ribeiro Guerra
- Universidade Federal de Juiz de Fora (UFJF) Programa de Pós-Graduação em Saúde Coletiva Juiz de Fora (MG) Brasil Universidade Federal de Juiz de Fora (UFJF), Programa de Pós-Graduação em Saúde Coletiva, Juiz de Fora (MG), Brasil
| | - Vinícius de Azevedo Couto Firme
- Universidade Federal de Juiz de Fora - Campus Governador Valadares (UFJF/GV) Governador Valadares (MG) Brasil Universidade Federal de Juiz de Fora - Campus Governador Valadares (UFJF/GV), Governador Valadares (MG), Brasil
| | - Maria Teresa Bustamante-Teixeira
- Universidade Federal de Juiz de Fora (UFJF) Programa de Pós-Graduação em Saúde Coletiva Juiz de Fora (MG) Brasil Universidade Federal de Juiz de Fora (UFJF), Programa de Pós-Graduação em Saúde Coletiva, Juiz de Fora (MG), Brasil
| |
Collapse
|
54
|
Ayres ARG, Silva GAE, Teixeira MTB, Duque KDCD, Machado MLSM, Gamarra CJ, Levi JE. HPV in women assisted by the Family Health Strategy. Rev Saude Publica 2017; 51:92. [PMID: 29020120 PMCID: PMC5676731 DOI: 10.11606/s1518-8787.2017051000065] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2016] [Accepted: 01/05/2017] [Indexed: 11/13/2022] Open
Abstract
OBJECTIVE Estimate the prevalence of cervical HPV infection among women assisted by the Family Health Strategy and identify the factors related to the infection. METHODS A cross-sectional study involving 2,076 women aged 20–59 years old residing in Juiz de Fora, State of Minas Gerais, who were asked to participate in an organized screening carried out in units were the Family Health Strategy had been implemented. Participants answered the standardized questionnaire and underwent a conventional cervical cytology test and HPV test for high oncogenic risk. Estimates of HPV infection prevalence were calculated according to selected characteristics referenced in the literature and related to socioeconomic status, reproductive health and lifestyle. RESULTS The overall prevalence of HPV infection was 12.6% (95%CI 11.16–14.05). The prevalence for the pooled primer contained 12 oncogenic HPV types (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68) was 8.6% (95%CI 7.3–9.77). In the multivariate analysis, it was observed that the following variables were significantly associated with a higher prevalence of HPV infection: marital status (single: adjusted PR = 1.40, 95%CI 1.07–1.8), alcohol consumption (any lifetime frequency: adjusted PR = 1.44, 95%CI 1.11–1.86) and number of lifetime sexual partners (≥ 3: adjusted PR = 1.35, 95%CI 1.04–1.74). CONCLUSIONS The prevalence of HPV infection in the study population ranges from average to particularly high among young women. The prevalence of HPV16 and HPV18 infection is similar to the worldwide prevalence. Homogeneous distribution among the pooled primer types would precede the isolated infection by HPV18 in magnitude, which may be a difference greater than the one observed. The identification of high-risk oncogenic HPV prevalence may help identify women at higher risk of developing preneoplastic lesions.
Collapse
Affiliation(s)
| | - Gulnar Azevedo E Silva
- Departamento de Epidemiologia. Instituto de Medicina Social. Universidade do Estado do Rio de Janeiro. Rio de Janeiro, RJ, Brasil
| | | | | | | | - Carmen Justina Gamarra
- Faculdade de Saúde Coletiva. Universidade Federal da Integração Latino-Americana. Foz do Iguaçu, PR, Brasil
| | - José Eduardo Levi
- Laboratório de Virologia. Instituto de Medicina Tropical. Universidade de São Paulo. São Paulo, SP, Brasil
| |
Collapse
|
55
|
Diniz CSG, Pellini ACG, Ribeiro AG, Tedardi MV, de Miranda MJ, Touso MM, Baquero OS, dos Santos PC, Chiaravalloti-Neto F. Breast cancer mortality and associated factors in São Paulo State, Brazil: an ecological analysis. BMJ Open 2017; 7:e016395. [PMID: 28838894 PMCID: PMC5629728 DOI: 10.1136/bmjopen-2017-016395] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/10/2017] [Revised: 06/09/2017] [Accepted: 07/05/2017] [Indexed: 12/29/2022] Open
Abstract
OBJECTIVE Identify the factors associated with the age-standardised breast cancer mortality rate in the municipalities of State of São Paulo (SSP), Brazil, in the period from 2006 to 2012. DESIGN Ecological study of the breast cancer mortality rate standardised by age, as the dependent variable, having each of the 645 municipalities in the SSP as the unit of analysis. SETTINGS The female resident population aged 15 years or older, by age group and municipality, in 2009 (mid-term), obtained from public dataset (Informatics Department of the Unified Health System). PARTICIPANTS Women 15 years or older who died of breast cancer in the SSP were selected for the calculation of the breast cancer mortality rate, according to the municipality and age group, from 2006 to 2012. MAIN OUTCOME MEASURES Mortality rates for each municipality calculated by the direct standardisation method, using the age structure of the population of SSP in 2009 as the standard. RESULTS In the final linear regression model, breast cancer mortality, in the municipal level, was directly associated with rates of nulliparity (p<0.0001), mammography (p<0.0001) and private healthcare (p=0.006). CONCLUSIONS The findings that mammography ratio was associated, in the municipal level, with increased mortality add to the evidence of a probable overestimation of benefits and underestimation of risks associated with this form of screening. The same paradoxical trend of increased mortality with screening was found in recent individual-level studies, indicating the need to expand informed choice for patients, primary prevention actions and individualised screening. Additional studies should be conducted to explore if there is a causality link in this association.
Collapse
Affiliation(s)
- Carmen Simone Grilo Diniz
- Departamento de Saúde, Ciclos de Vida e Sociedade da Faculdade de Saúde Pública, Universidade de São Paulo, São Paulo, Brazil
| | | | - Adeylson Guimarães Ribeiro
- Departamento de Saúde Ambiental, Faculdade de Saúde Pública, Universidade de São Paulo, São Paulo, Brazil
| | - Marcello Vannucci Tedardi
- Departamento de Patologia, Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo, São Paulo, Brazil
| | - Marina Jorge de Miranda
- Departamento de Saúde, Ciclos de Vida e Sociedade da Faculdade de Saúde Pública, Universidade de São Paulo, São Paulo, Brazil
| | - Michelle Mosna Touso
- Departamento de Enfermagem Materno-Infantil e Saúde Pública, Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo, São Paulo, Brazil
| | - Oswaldo Santos Baquero
- Departamento de Medicina Veterinária Preventiva, Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo, São Paulo, Brazil
| | - Patrícia Carlos dos Santos
- Secretaria Municipal de Saúde de São Paulo, Coordenação de Epidemiologia e Informação, São Paulo, Brazil
| | | |
Collapse
|
56
|
Silva GAE, de Souza-Júnior PRB, Damacena GN, Szwarcwald CL. Early detection of breast cancer in Brazil: data from the National Health Survey, 2013. Rev Saude Publica 2017; 51:14s. [PMID: 28591356 PMCID: PMC5676402 DOI: 10.1590/s1518-8787.2017051000191] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2016] [Accepted: 09/06/2016] [Indexed: 11/22/2022] Open
Abstract
OBJECTIVE To analyze whether the actions of early detection of breast cancer, initiated with the medical request for mammography, differ between users of the Brazilian Unified Health System (SUS) and those who have private health insurance. METHODS From the data collected in the National Health Survey, we estimated the proportions of women who had medical request for mammography according to presence or absence of private health insurance. For assessing the factors related to having mammography medical request, we estimated crude and adjusted odds ratios and respective 95%CI by logistic regression. We also analyzed the main reasons reported for not having performed mammography after medical request, as well as the time between examination and result. RESULTS Of the women interviewed, 66.7% had a medical request for mammography (59.4% among SUS users and 83.9% among those with private health insurance). Having private health insurance, higher education level, and being white were positively associated with having the medical request. Only 5.4% (95%CI 4.8-6.0) of women who received medical request failed to perform mammography - 7.6% were SUS users and 1.7% had health insurance. The most reported reasons for not being able to perform the examination were: not thinking it was necessary; having the test scheduled, but not yet performed; and not being able to schedule it. More than 70% of women received the result with less than one month from its execution. CONCLUSIONS The barriers to access a medical request for mammographic screening for breast cancer are higher among women who depend exclusively on SUS.
Collapse
Affiliation(s)
- Gulnar Azevedo e Silva
- Departamento de Epidemiologia. Instituto de Medicina Social. Universidade do Estado do Rio de Janeiro. Rio de Janeiro, RJ, Brasil
| | - Paulo Roberto Borges de Souza-Júnior
- Laboratório de Informações em Saúde. Instituto de Comunicação e Informação Científica e Tecnológica em Saúde. Fundação Oswaldo Cruz. Rio de Janeiro, RJ, Brasil
| | - Giseli Nogueira Damacena
- Laboratório de Informações em Saúde. Instituto de Comunicação e Informação Científica e Tecnológica em Saúde. Fundação Oswaldo Cruz. Rio de Janeiro, RJ, Brasil
| | - Célia Landmann Szwarcwald
- Laboratório de Informações em Saúde. Instituto de Comunicação e Informação Científica e Tecnológica em Saúde. Fundação Oswaldo Cruz. Rio de Janeiro, RJ, Brasil
| |
Collapse
|
57
|
The Rise in Mortality from Breast Cancer in Young Women: Trend Analysis in Brazil. PLoS One 2017; 12:e0168950. [PMID: 28046087 PMCID: PMC5207532 DOI: 10.1371/journal.pone.0168950] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2016] [Accepted: 12/08/2016] [Indexed: 12/13/2022] Open
Abstract
Introduction Breast cancer is the most common cause of cancer death among women. Objective The objective of this study was to analyze time trends in overall mortality from breast cancer in Brazil, Brazilian regions and States. Methods This is an exploratory study, of the time series of deaths from breast cancer contained in the Mortality Information System (SIM), of women living in Brazil, Brazilian regions and States, from 1996 to 2013. For the trend analysis, the polynomial regression model was used, and a significant trend was considered when the estimated model obtained a p value <0.05. Results There was a tendency of increased mortality from breast cancer in Brazilian women (average increase of 0.18 per year; p <0.001), with regional differences, particularly in the age group 20–49 years (0.07 per year; p <0.001). The age group 50–69 years remained constant but had high average rates (37.14). Conclusion More effective planning is needed to focus on the different scenarios of the Brazilian regions. Screening strategies for the incidence and mortality from breast cancer must also be rethought according to age group in the country.
Collapse
|
58
|
Teixeira MDS, Goldman RE, Gonçalves VCS, Gutiérrez MGRD, Figueiredo END. Atuação do enfermeiro da Atenção Primária no controle do câncer de mama. ACTA PAUL ENFERM 2017. [DOI: 10.1590/1982-0194201700002] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Resumo Objetivo Analisar as ações realizadas por enfermeiros da Atenção Primária em Saúde para rastreamento oportunístico do câncer de mama, tendo como parâmetro a proposta do Ministério da Saúde. Métodos Estudo descritivo, transversal, realizado com 70 enfermeiros, com auxílio de questionário validado, elaborado segundo as ações determinadas pelo programa de controle de câncer de mama do Brasil. Resultados 97,1% dos enfermeiros realizavam exame clínico das mamas, 88,6% indicaram a mamografia anualmente e 75,7% orientaram o primeiro exame a partir dos 40 anos e 52,9% promoviam reuniões educativas. Entretanto, a orientação sobre faixa etária e intervalo de tempo para mamografia e exame clínico das mamas, bem como busca ativa de mulheres faltosas não apresentavam conformidade com o preconizado. Conclusão Os enfermeiros têm realizado ações para o controle do câncer de mama, mas existem algumas não conformidades entre as ações executadas e as propostas do Ministério da Saúde para o rastreamento desta neoplasia.
Collapse
|
59
|
Theme Filha MM, Leal MDC, Oliveira EFVD, Esteves-Pereira AP, Gama SGND. Regional and social inequalities in the performance of Pap test and screening mammography and their correlation with lifestyle: Brazilian national health survey, 2013. Int J Equity Health 2016; 15:136. [PMID: 27852313 PMCID: PMC5112710 DOI: 10.1186/s12939-016-0430-9] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2016] [Accepted: 09/01/2016] [Indexed: 11/13/2022] Open
Abstract
Background Mass population screening for the early detection of cervical and breast cancer has been shown to be a safe and effective strategy worldwide and has reduced the incidence and mortality rates of these diseases. The aim of this study is to analyse the reach of screening tests for cervical and breast cancer according to sociodemographic variables and to analyse their correlation with a healthy lifestyle. Methods We have analysed data collected from 31.845 women aged 18 and over, who were interviewed for the Brazilian National Health Survey, a nationwide household inquiry, which took place between August 2013 and February 2014. The Pap tests performed in the last 3 years in women aged between 25 and 64 and screening mammogram performed in the last 2 years in women aged between 50 and 69 were considered adequate. We identified habits that constitute a healthy lifestyle, such as the consumption of five or more daily servings of fruits and vegetables, 30 min or more of leisurely physical activity and not smoking. Results We observed that the Pap test (78.8 %) was more widespread than the screening mammogram (54.5 %), with significant geographical and social differences concerning access to health care. Access for such screening was higher for women living in more developed regions (Southeast and South), who were white-skinned, better educated, living with a partner and, especially, who were covered by private health insurance. Those who underwent the tests according to established protocols also had a healthy lifestyle, which corroborates the healthy behaviour pattern of damage prevention. Conclusion Despite the progress made, social disparity still defines access to screening tests for cervical and breast cancer, with women covered by private health insurance tending to benefit the most. It is necessary to reduce social and regional inequalities and ensure a more uniform provision and access to the tests, especially for socially disadvantaged women, in order to reduce the incidence and mortality rate resulting from the aforementioned diseases.
Collapse
Affiliation(s)
- Mariza Miranda Theme Filha
- Department of Epidemiology and Quantitative Methods in Health, Sérgio Arouca National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil. .,Escola Nacional de Saúde Pública Sérgio Arouca-ENSP/FIOCRUZ, Rua Leopoldo Bulhões 1480 sala 813, Manguinhos, 20041-210, RJ, Brazil.
| | - Maria do Carmo Leal
- Department of Epidemiology and Quantitative Methods in Health, Sérgio Arouca National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil
| | - Elaine Fernandes Viellas de Oliveira
- Department of Epidemiology and Quantitative Methods in Health, Sérgio Arouca National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil
| | - Ana Paula Esteves-Pereira
- Department of Epidemiology and Quantitative Methods in Health, Sérgio Arouca National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil
| | - Silvana Granado Nogueira da Gama
- Department of Epidemiology and Quantitative Methods in Health, Sérgio Arouca National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil
| |
Collapse
|
60
|
Musselwhite LW, Oliveira CM, Kwaramba T, de Paula Pantano N, Smith JS, Fregnani JH, Reis RM, Mauad E, Vazquez FDL, Longatto-Filho A. Racial/Ethnic Disparities in Cervical Cancer Screening and Outcomes. Acta Cytol 2016; 60:518-526. [PMID: 27825171 DOI: 10.1159/000452240] [Citation(s) in RCA: 68] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2016] [Accepted: 10/03/2016] [Indexed: 12/15/2022]
Abstract
Invasive cervical cancer disproportionately affects women without sufficient access to care, with higher rates among minority groups in higher-income countries and women in low-resource regions of the world. Many elements contribute to racial/ethnic disparities in the cervical cancer continuum - from screening and diagnosis to treatment and outcome. Sociodemographic factors, access to healthcare, income and education level, and disease stage at diagnosis are closely linked to such inequities. Despite the identification of such elements, racial/ethnic disparities persist, and are widening in several minority subgroups, particularly in older women, who are ineligible for human papillomavirus (HPV) vaccination and are underscreened. Recent studies suggest that racial/ethnic differences in HPV infection exist and may also have a role in observed differences in cervical cancer. In this review, we provide an overview of the current literature on racial disparities in cervical cancer screening, incidence, treatment and outcome to inform future strategies to reduce persistent inequities.
Collapse
|
61
|
Ejzenberg D, Mendes LRBC, de Paiva Haddad LB, Baracat EC, D’Albuquerque LAC, Andraus W. Uterine transplantation: a systematic review. Clinics (Sao Paulo) 2016; 71:679-683. [PMID: 27982170 PMCID: PMC5108169 DOI: 10.6061/clinics/2016(11)10] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/15/2016] [Revised: 09/20/2016] [Accepted: 09/20/2016] [Indexed: 11/19/2022] Open
Abstract
Up to 15% of the reproductive population is infertile, and 3 to 5% of these cases are caused by uterine dysfunction. This abnormality generally leads women to consider surrogacy or adoption. Uterine transplantation, although still experimental, may be an option in these cases. This systematic review will outline the recommendations, surgical aspects, immunosuppressive drugs and reproductive aspects related to experimental uterine transplantation in women.
Collapse
Affiliation(s)
- Dani Ejzenberg
- Departamento de Ginecologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo/SP, Brasil
| | | | | | - Edmund Chada Baracat
- Departamento de Ginecologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo/SP, Brasil
| | | | - Wellington Andraus
- Divisão de transplante de Órgãos Digestivos, Faculdade de Medicina da Universidade de São Paulo, São Paulo/SP, Brasil
| |
Collapse
|
62
|
Correlation between indoleamine 2,3 dioxygenase mRNA and CDKN2A/p16 mRNA: a combined strategy to cervical cancer diagnosis. Med Oncol 2016; 33:132. [DOI: 10.1007/s12032-016-0844-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2016] [Accepted: 10/05/2016] [Indexed: 11/27/2022]
|
63
|
Pinho-França JDR, Chein MBDC, Thuler LCS. Patterns of cervical cytological abnormalities according to the Human Development Index in the northeast region of Brazil. BMC WOMENS HEALTH 2016; 16:54. [PMID: 27516107 PMCID: PMC4982310 DOI: 10.1186/s12905-016-0334-2] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/12/2015] [Accepted: 08/02/2016] [Indexed: 12/30/2022]
Abstract
BACKGROUND Disparities in cancer incidence and mortality rates between regions arise due to differences in socioeconomic conditions and in human development factors. The major purpose of this study was to measure the role of the Human Development Index (HDI) in the pattern of cervical cytological abnormalities (CCAs). METHODS This was an analytical sectional study involving a review of secondary cervical cytology data collected from women living in the state of Maranhão, Brazil, in 2007-2012 and collected from the Cervical Cancer Information System (Sistema de Informação do Câncer do Colo do Útero - SISCOLO). The cervical screening results were classified according to the Brazilian Classification of Cervical Reporting (Nomenclatura Brasileira para Laudos Cervicais), an adaptation of the Bethesda System. The Municipal Human Development Index (MHDI) was used, which is an adaptation of the global HDI. The association between CCAs and MHDI was evaluated using the chi-squared test and odds ratios (ORs) with 95 % confidence intervals (95 % CI). The significance level used for all tests was 5 %. RESULTS We analysed 1,363,689 examinations of women living in the state of Maranhão. CCAs were identified in 2.0 % of smears in municipalities with high MHDI, 2.2 % in those with medium or low MHDI and 4.1 % in those with very low MHDI. In addition, potentially malignant changes and suspected cervical cancer (HSIL+) were 40.0 % more frequent (0.3 %) in municipalities with medium or low MHDI and 3.6 times more frequent (0.8 %) in municipalities with very low MHDI compared to those with high MHDI (0.2 %). CONCLUSION The association between MHDI and the occurrence of CCAs and HSIL+ shows that more developed areas with more effective health services have a lower prevalence of these lesions. To control cervical cancer, it is necessary to reduce social inequality and improve the availability of health services.
Collapse
Affiliation(s)
- José De Ribamar Pinho-França
- Department of Medicine III, Federal University of Maranhão (Universidade Federal do Maranhão), Praça Gonçalves Dias, 21/2° andar, Centro, São Luís, MA, 65020-240, Brazil.
| | - Maria Bethânia Da Costa Chein
- Department of Medicine III, Federal University of Maranhão (Universidade Federal do Maranhão), Praça Gonçalves Dias, 21/2° andar, Centro, São Luís, MA, 65020-240, Brazil
| | - Luiz Claudio Santos Thuler
- Graduate Program in Oncology, National Cancer Institute (Instituto Nacional de Câncer), Rua André Cavalcanti, 37/2° andar, Centro, Rio de Janeiro, 20231-050, Brazil
| |
Collapse
|
64
|
Vale DB, Sauvaget C, Muwonge R, Ferlay J, Zeferino LC, Murillo R, Sankaranarayanan R. Disparities in time trends of cervical cancer mortality rates in Brazil. Cancer Causes Control 2016; 27:889-96. [PMID: 27255650 DOI: 10.1007/s10552-016-0766-x] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2016] [Accepted: 05/18/2016] [Indexed: 10/21/2022]
Abstract
PURPOSE This study aimed to correct and describe cervical cancer mortality rates and trends by regions and age-groups in Brazil. It may help planning and implementing policies for cervical cancer control. METHODS Data from 2003 to 2012 were accessed through the centralized national mortality database. Correction of the age-specific mortality rates was done by proportional redistribution of ill-defined causes of death and deaths coded as 'uterine, part unspecified'. Annual percentage change (APC) was obtained by trend analysis (Joinpoint regression). RESULTS In the 10-year period, cancer and ill-defined causes corresponded, respectively, to 18.9 and 10.8 % of all deaths (except injuries). The proportion of ill-defined causes was reduced by more than a half in the period. The age-standardized cervical cancer mortality rate was 7.2 per 100,000 women-years after correction. The total increase in rates after corrections was 50.5 %. A significant decreasing trend in rates was observed at the national level (APC = -0.17, p < 0.001). North was the only region that did not show a decreasing significant trend (APC + 0.07, p = 0.28). Decreasing trends were restricted to age-groups over 40 years. CONCLUSIONS A consistent decreasing trend of cervical cancer mortality rates in Brazil from 2003 to 2012 was observed, although this was not consistent in all regions and restricted to older age-groups. Quality of data needs to be improved. Cancer control policies may consider the differences in access to care and the characteristics of regions to improve their efficiency.
Collapse
Affiliation(s)
- Diama Bhadra Vale
- Section of Early Detection and Prevention, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372, Lyon Cedex 08, France.
- Department of Obstetrics and Gynecology, State University of Campinas, Caixa Postal 6111, Campinas, 13081-970, Brazil.
| | - Catherine Sauvaget
- Section of Early Detection and Prevention, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372, Lyon Cedex 08, France
| | - Richard Muwonge
- Section of Early Detection and Prevention, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372, Lyon Cedex 08, France
| | - Jacques Ferlay
- Section of Cancer Surveillance, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372, Lyon, France
| | - Luiz Carlos Zeferino
- Department of Obstetrics and Gynecology, State University of Campinas, Caixa Postal 6111, Campinas, 13081-970, Brazil
| | - Raul Murillo
- Section of Early Detection and Prevention, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372, Lyon Cedex 08, France
| | - Rengaswamy Sankaranarayanan
- Section of Early Detection and Prevention, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372, Lyon Cedex 08, France
| |
Collapse
|
65
|
de Paula Paz CR, Reis Pessalacia JD, Campos Pavone Zoboli EL, Ludugério de Souza H, Ferreira Granja G, Cabral Schveitzer M. New demands for primary health care in Brazil: palliative care. INVESTIGACION Y EDUCACION EN ENFERMERIA 2016; 34:46-57. [PMID: 28569973 DOI: 10.17533/udea.iee.v34n1a06] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/22/2015] [Accepted: 09/01/2015] [Indexed: 06/07/2023]
Abstract
OBJECTIVE Assess the need for incorporation of palliative care in primary health care (PHC) through the characterization of users eligible for this type of care, enrolled in a program for devices dispensing. METHODS Descriptive study of case series conducted in 14 health units in São Paulo (Brazil) in 2012. It was included medical records of those enrolled in a program for users with urinary and fecal incontinence, and it was applied Karnofsky Performance Scale Index (KPS) to identify the indication of palliative care. RESULTS 141 of the 160 selected medical records had KPS information. Most cases (98.3%, 138/141) had performance below 70% and, therefore, patients were eligible for palliative care. The most frequent pathologies was related to chronic degenerative diseases (46.3%), followed by disorders related to quality of care during pregnancy and childbirth (24.38%). CONCLUSION It is necessary to include palliative care in PHC in order to provide comprehensive, shared and humanized care to patients who need this.
Collapse
|
66
|
Strasser-Weippl K, Chavarri-Guerra Y, Villarreal-Garza C, Bychkovsky BL, Debiasi M, Liedke PER, Soto-Perez-de-Celis E, Dizon D, Cazap E, de Lima Lopes G, Touya D, Nunes JS, St Louis J, Vail C, Bukowski A, Ramos-Elias P, Unger-Saldaña K, Brandao DF, Ferreyra ME, Luciani S, Nogueira-Rodrigues A, de Carvalho Calabrich AF, Del Carmen MG, Rauh-Hain JA, Schmeler K, Sala R, Goss PE. Progress and remaining challenges for cancer control in Latin America and the Caribbean. Lancet Oncol 2016; 16:1405-38. [PMID: 26522157 DOI: 10.1016/s1470-2045(15)00218-1] [Citation(s) in RCA: 129] [Impact Index Per Article: 16.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2015] [Revised: 08/03/2015] [Accepted: 08/04/2015] [Indexed: 12/22/2022]
Abstract
Cancer is one of the leading causes of mortality worldwide, and an increasing threat in low-income and middle-income countries. Our findings in the 2013 Commission in The Lancet Oncology showed several discrepancies between the cancer landscape in Latin America and more developed countries. We reported that funding for health care was a small percentage of national gross domestic product and the percentage of health-care funds diverted to cancer care was even lower. Funds, insurance coverage, doctors, health-care workers, resources, and equipment were also very inequitably distributed between and within countries. We reported that a scarcity of cancer registries hampered the design of credible cancer plans, including initiatives for primary prevention. When we were commissioned by The Lancet Oncology to write an update to our report, we were sceptical that we would uncover much change. To our surprise and gratification much progress has been made in this short time. We are pleased to highlight structural reforms in health-care systems, new programmes for disenfranchised populations, expansion of cancer registries and cancer plans, and implementation of policies to improve primary cancer prevention.
Collapse
Affiliation(s)
- Kathrin Strasser-Weippl
- Centre for Oncology and Hematology, Wilhelminen Hospital, Vienna, Austria; The Global Cancer Institute, Boston, MA, USA
| | - Yanin Chavarri-Guerra
- The Global Cancer Institute, Boston, MA, USA; Hemato-Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico City, Mexico; Avon International Breast Cancer Research Program, Massachusetts General Hospital, Boston, MA, USA
| | - Cynthia Villarreal-Garza
- Instituto de Cancerología, Centro de Cáncer de Mama, Tecnologico de Monterrey, Monterrey, Nuevo León, Mexico; Departmento de Investigación y de Tumores Mamarios, Instituto Nacional de Cancerologia, Mexico City, Mexico
| | - Brittany L Bychkovsky
- Dana Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA
| | - Marcio Debiasi
- Hospital Mae de Deus, Porto Alegre, Rio Grande do Sul, Brazil; Hospital Sao Lucas da PUCRS, Porto Alegre, Rio Grande do Sul, Brazil
| | - Pedro E R Liedke
- Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil; Instituto do Câncer Mãe de Deus, Porto Alegre, Rio Grande do Sul, Brazil
| | - Enrique Soto-Perez-de-Celis
- Department of Geriatrics, Cancer Care in the Elderly Clinic, Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico City, Mexico
| | - Don Dizon
- Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA
| | - Eduardo Cazap
- Sociedad Latinoamericana y del Caribe de Oncología Médica, Buenos Aires, Argentina
| | - Gilberto de Lima Lopes
- Medical Oncology, Centro Paulista de Oncologia and Oncoclinicas do Brasil Group, São Paulo, Brazil; Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Diego Touya
- Department of Oncology, University of the Republic, Montevideo, Uruguay
| | | | - Jessica St Louis
- The Global Cancer Institute, Boston, MA, USA; Avon International Breast Cancer Research Program, Massachusetts General Hospital, Boston, MA, USA
| | - Caroline Vail
- The Global Cancer Institute, Boston, MA, USA; Avon International Breast Cancer Research Program, Massachusetts General Hospital, Boston, MA, USA
| | - Alexandra Bukowski
- The Global Cancer Institute, Boston, MA, USA; Avon International Breast Cancer Research Program, Massachusetts General Hospital, Boston, MA, USA
| | - Pier Ramos-Elias
- Instituto de Cancerología, Centro de Cáncer de Mama, Tecnologico de Monterrey, Monterrey, Nuevo León, Mexico
| | - Karla Unger-Saldaña
- Cátedra CONACYT, Unidad de Epidemiología, Instituto Nacional de Cancerologia, Mexico City, Mexico
| | | | - Mayra E Ferreyra
- Oncology Department, Maria Curie Hospital, Buenos Aires, Argentina
| | - Silvana Luciani
- Department of Noncommunicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, USA
| | - Angelica Nogueira-Rodrigues
- Federal University, Minas Gerais, Brazil; EVA-Group Brasileiro de Tumores Ginecológicos, Brazilian Gynecologic Oncology Group, Bahia, Brazil
| | | | - Marcela G Del Carmen
- Division of Gynecologic Oncology, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA
| | - Jose Alejandro Rauh-Hain
- Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA
| | | | - Raúl Sala
- Grupo Argentino de Investigación Clínica en Oncología-GAICO, Rosario, Santa Fe, Argentina
| | - Paul E Goss
- The Global Cancer Institute, Boston, MA, USA; Avon International Breast Cancer Research Program, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
| |
Collapse
|
67
|
de Souza JA, Hunt B, Asirwa FC, Adebamowo C, Lopes G. Global Health Equity: Cancer Care Outcome Disparities in High-, Middle-, and Low-Income Countries. J Clin Oncol 2016; 34:6-13. [PMID: 26578608 PMCID: PMC5795715 DOI: 10.1200/jco.2015.62.2860] [Citation(s) in RCA: 127] [Impact Index Per Article: 15.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
Breakthroughs in our global fight against cancer have been achieved. However, this progress has been unequal. In low- and middle-income countries and for specific populations in high-income settings, many of these advancements are but an aspiration and hope for the future. This review will focus on health disparities in cancer within and across countries, drawing from examples in Kenya, Brazil, and the United States. Placed in context with these examples, the authors also draw basic recommendations from several initiatives and groups that are working on the issue of global cancer disparities, including the US Institute of Medicine, the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, and the Union for International Cancer Control. From increasing initiatives in basic resources in low-income countries to rapid learning systems in high-income countries, the authors argue that beyond ethics and equity issues, it makes economic sense to invest in global cancer control, especially in low- and middle-income countries.
Collapse
Affiliation(s)
- Jonas A de Souza
- Jonas A. de Souza, The University of Chicago Medical Center and Bucksbaum Institute for Clinical Excellence; Bijou Hunt, Sinai Urban Health Institute, Mount Sinai Hospital, Chicago, IL; Fredrick Chite Asirwa, Indiana University School of Medicine, Indianapolis, IN, and Moi University School of Medicine, Eldoret, Kenya; Clement Adebamowo, Institute of Human Virology and Greenebaum Cancer Center, School of Medicine, University of Maryland; Gilberto Lopes, Johns Hopkins University School of Medicine, Baltimore, MD, and Centro Paulista de Oncologia and Oncoclinicas do Brasil Group, Sao Paulo, Brazil
| | - Bijou Hunt
- Jonas A. de Souza, The University of Chicago Medical Center and Bucksbaum Institute for Clinical Excellence; Bijou Hunt, Sinai Urban Health Institute, Mount Sinai Hospital, Chicago, IL; Fredrick Chite Asirwa, Indiana University School of Medicine, Indianapolis, IN, and Moi University School of Medicine, Eldoret, Kenya; Clement Adebamowo, Institute of Human Virology and Greenebaum Cancer Center, School of Medicine, University of Maryland; Gilberto Lopes, Johns Hopkins University School of Medicine, Baltimore, MD, and Centro Paulista de Oncologia and Oncoclinicas do Brasil Group, Sao Paulo, Brazil
| | - Fredrick Chite Asirwa
- Jonas A. de Souza, The University of Chicago Medical Center and Bucksbaum Institute for Clinical Excellence; Bijou Hunt, Sinai Urban Health Institute, Mount Sinai Hospital, Chicago, IL; Fredrick Chite Asirwa, Indiana University School of Medicine, Indianapolis, IN, and Moi University School of Medicine, Eldoret, Kenya; Clement Adebamowo, Institute of Human Virology and Greenebaum Cancer Center, School of Medicine, University of Maryland; Gilberto Lopes, Johns Hopkins University School of Medicine, Baltimore, MD, and Centro Paulista de Oncologia and Oncoclinicas do Brasil Group, Sao Paulo, Brazil
| | - Clement Adebamowo
- Jonas A. de Souza, The University of Chicago Medical Center and Bucksbaum Institute for Clinical Excellence; Bijou Hunt, Sinai Urban Health Institute, Mount Sinai Hospital, Chicago, IL; Fredrick Chite Asirwa, Indiana University School of Medicine, Indianapolis, IN, and Moi University School of Medicine, Eldoret, Kenya; Clement Adebamowo, Institute of Human Virology and Greenebaum Cancer Center, School of Medicine, University of Maryland; Gilberto Lopes, Johns Hopkins University School of Medicine, Baltimore, MD, and Centro Paulista de Oncologia and Oncoclinicas do Brasil Group, Sao Paulo, Brazil
| | - Gilberto Lopes
- Jonas A. de Souza, The University of Chicago Medical Center and Bucksbaum Institute for Clinical Excellence; Bijou Hunt, Sinai Urban Health Institute, Mount Sinai Hospital, Chicago, IL; Fredrick Chite Asirwa, Indiana University School of Medicine, Indianapolis, IN, and Moi University School of Medicine, Eldoret, Kenya; Clement Adebamowo, Institute of Human Virology and Greenebaum Cancer Center, School of Medicine, University of Maryland; Gilberto Lopes, Johns Hopkins University School of Medicine, Baltimore, MD, and Centro Paulista de Oncologia and Oncoclinicas do Brasil Group, Sao Paulo, Brazil.
| |
Collapse
|
68
|
Costa RFA, Longatto-Filho A, Pinheiro C, Zeferino LC, Fregnani JH. Historical Analysis of the Brazilian Cervical Cancer Screening Program from 2006 to 2013: A Time for Reflection. PLoS One 2015; 10:e0138945. [PMID: 26402737 PMCID: PMC4581862 DOI: 10.1371/journal.pone.0138945] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2015] [Accepted: 09/05/2015] [Indexed: 12/22/2022] Open
Abstract
Background The Cervical Cancer Database of the Brazilian National Health Service (SISCOLO) contains information regarding all cervical cytological tests and, if properly explored, can be used as a tool for monitoring and managing the cervical cancer screening program. The aim of this study was to perform a historical analysis of the cervical cancer screening program in Brazil from 2006 to 2013. Material and Methods The data necessary to calculate quality indicators were obtained from the SISCOLO, a Brazilian health system tool. Joinpoint analysis was used to calculate the annual percentage change. Results We observed important trends showing decreased rates of low-grade squamous intraepithelial lesions (LSIL) and high-grade squamous intraepithelial lesions (HSIL) and an increased rate of rejected exams from 2009 to 2013. The index of positivity was maintained at levels below those indicated by international standards; very low frequencies of unsatisfactory cases were observed over the study period, which partially contradicts the low rate of positive cases. The number of positive cytological diagnoses was below that expected, considering that developed countries with low frequencies of cervical cancer detect more lesions annually. Conclusions The evolution of indicators from 2006 to 2013 suggests that actions must be taken to improve the effectiveness of cervical cancer control in Brazil.
Collapse
Affiliation(s)
- Ricardo Filipe Alves Costa
- Graduate Program of Oncology, Barretos Cancer Hospital, Barretos, São Paulo, Brazil
- Barretos School of Health Sciences Dr. Paulo Prata – FACISB, Barretos, São Paulo, Brazil
- * E-mail:
| | - Adhemar Longatto-Filho
- Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil
- Laboratory of Medical Investigation (LIM 14), Faculty of Medicine, São Paulo University, FMUSP, São Paulo, Brazil
- Life and Health Sciences Research Institute, ICVS, School of Health Sciences, Minho University, Braga, Portugal
- ICVS/3B’s - PT Government Associate Laboratory, Braga/Guimarães, Portugal
| | - Céline Pinheiro
- Barretos School of Health Sciences Dr. Paulo Prata – FACISB, Barretos, São Paulo, Brazil
- Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil
| | - Luiz Carlos Zeferino
- School of Medical Sciences, Women’s Hospital CAISM, Unicamp, Campinas, São Paulo, Brazil
| | | |
Collapse
|